advertisement
Ishida S 9
Showing records 1 to 9 | Display all abstracts from Ishida S106022 Reduction of Intraocular Pressure and Aqueous Outflow Resistance after Modified 360-degree Suture Trabeculotomy
Suzuki K
Journal of Glaucoma 2023; 32: 204-209
106284 Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degeneration
Ando R
Japanese Journal of Ophthalmology 2023; 67: 50-58
106022 Reduction of Intraocular Pressure and Aqueous Outflow Resistance after Modified 360-degree Suture Trabeculotomy
Shinmei Y
Journal of Glaucoma 2023; 32: 204-209
106284 Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degeneration
Hirooka K; Saito M
Japanese Journal of Ophthalmology 2023; 67: 50-58
106022 Reduction of Intraocular Pressure and Aqueous Outflow Resistance after Modified 360-degree Suture Trabeculotomy
Hirooka K
Journal of Glaucoma 2023; 32: 204-209
106284 Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degeneration
Kase S
Japanese Journal of Ophthalmology 2023; 67: 50-58
106022 Reduction of Intraocular Pressure and Aqueous Outflow Resistance after Modified 360-degree Suture Trabeculotomy
Kanaya R; Shinkai A
Journal of Glaucoma 2023; 32: 204-209
106284 Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degeneration
Noda K; Ishida S
Japanese Journal of Ophthalmology 2023; 67: 50-58
106022 Reduction of Intraocular Pressure and Aqueous Outflow Resistance after Modified 360-degree Suture Trabeculotomy
Kijima R; Chin S; Ito YM; Ishida S
Journal of Glaucoma 2023; 32: 204-209
